APA

Baron F., Maris M. B., Storer B. E., Sandmaier B. M., Panse J. P., Chauncey T. R., Sorror M., Little M., Maloney D. G., Storb R. & Heimfeld S. (20050610). High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. : Leukemia.

Chicago

Baron F, Maris M B, Storer B E, Sandmaier B M, Panse J P, Chauncey T R, Sorror M, Little M-T, Maloney D G, Storb R and Heimfeld S. 20050610. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. : Leukemia.

Harvard

Baron F., Maris M. B., Storer B. E., Sandmaier B. M., Panse J. P., Chauncey T. R., Sorror M., Little M., Maloney D. G., Storb R. and Heimfeld S. (20050610). High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. : Leukemia.

MLA

Baron F, Maris M B, Storer B E, Sandmaier B M, Panse J P, Chauncey T R, Sorror M, Little M-T, Maloney D G, Storb R and Heimfeld S. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. : Leukemia. 20050610.